SLC39A7 and breast carcinoma: Taylor et al. found that an increased expression of ZIP7 in the endoplasmic reticulum was related to an enhanced intracellular zinc release in breast cancer cells, which augmented activation of the EGFR and could explain aggravated anti-tumour-therapy [22].